International Pharmaceutical Products Inc said Eli Lilly and Co has filed a patent infringement suit against it for marketing Vincristine Sulfate for injection. International Pharmaceutical said it believes that becaue of differences in formulation, it is not infringing on Eli Lilly's patent. Vincristine Sulfate is a chemotherapeutic product used to treat cancer. 